Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Subacute Neuropsychiatric Syndrome in Girls With SHANK3 Mutations Responds to Immunomodulation.

Bey AL, Gorman MP, Gallentine W, Kohlenberg TM, Frankovich J, Jiang YH, Van Haren K.

Pediatrics. 2020 Feb;145(2). pii: e20191490. doi: 10.1542/peds.2019-1490.

PMID:
32015180
2.

Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient.

Cellucci T, Van Mater H, Graus F, Muscal E, Gallentine W, Klein-Gitelman MS, Benseler SM, Frankovich J, Gorman MP, Van Haren K, Dalmau J, Dale RC.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 17;7(2). pii: e663. doi: 10.1212/NXI.0000000000000663. Print 2020 Mar.

3.

Genetic and phenotypic spectrum associated with IFIH1 gain-of-function.

Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Van Eyck L, Seabra L, Barrea C, Battini R, Belot A, Berg S, Billette de Villemeur T, Bley AE, Blumkin L, Boespflug-Tanguy O, Briggs TA, Brimble E, Dale RC, Darin N, Debray FG, De Giorgis V, Denecke J, Doummar D, Drake Af Hagelsrum G, Eleftheriou D, Estienne M, Fazzi E, Feillet F, Galli J, Hartog N, Harvengt J, Heron B, Heron D, Kelly DA, Lev D, Levrat V, Livingston JH, Marti I, Mignot C, Mochel F, Nougues MC, Oppermann I, Pérez-Dueñas B, Popp B, Rodero MP, Rodriguez D, Saletti V, Sharpe C, Tonduti D, Vadlamani G, Van Haren K, Tomas Vila M, Vogt J, Wassmer E, Wiedemann A, Wilson CJ, Zerem A, Zweier C, Zuberi SM, Orcesi S, Vanderver AL, Hur S, Crow YJ.

Hum Mutat. 2020 Apr;41(4):837-849. doi: 10.1002/humu.23975. Epub 2020 Jan 14.

4.

Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.

Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN.

Brain. 2020 Feb 1;143(2):503-511. doi: 10.1093/brain/awz390.

PMID:
31840744
5.

Pneumonia Prevention Strategies for Children With Neurologic Impairment.

Lin JL, Van Haren K, Rigdon J, Saynina O, Song H, Buu MC, Thakur Y, Srinivas N, Asch SM, Sanders LM.

Pediatrics. 2019 Oct;144(4). pii: e20190543. doi: 10.1542/peds.2019-0543. Epub 2019 Sep 19.

PMID:
31537634
6.

Incidence, Risk Factors and Outcomes Among Children With Acute Flaccid Myelitis: A Population-based Cohort Study in a California Health Network Between 2011 and 2016.

Kane MS, Sonne C, Zhu S, Malhotra A, Van Haren K, Messacar K, Glaser CA.

Pediatr Infect Dis J. 2019 Jul;38(7):667-672. doi: 10.1097/INF.0000000000002276.

PMID:
30985511
7.

Measuring early lesion growth in boys with cerebral demyelinating adrenoleukodystrophy.

van Haren K, Engelen M, Wolf N.

Neurology. 2019 Apr 9;92(15):691-693. doi: 10.1212/WNL.0000000000007256. Epub 2019 Mar 22. No abstract available.

PMID:
30902909
8.

Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016.

Elrick MJ, Gordon-Lipkin E, Crawford TO, Van Haren K, Messacar K, Thornton N, Dee E, Voskertchian A, Nance JR, Muñoz LS, Gorman MP, Benson LA, Thomas DL, Pardo CA, Milstone AM, Duggal P.

JAMA Pediatr. 2019 Feb 1;173(2):134-139. doi: 10.1001/jamapediatrics.2018.4890.

9.

Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis.

Messacar K, Sillau S, Hopkins SE, Otten C, Wilson-Murphy M, Wong B, Santoro JD, Treister A, Bains HK, Torres A, Zabrocki L, Glanternik JR, Hurst AL, Martin JA, Schreiner T, Makhani N, DeBiasi RL, Kruer MC, Tremoulet AH, Van Haren K, Desai J, Benson LA, Gorman MP, Abzug MJ, Tyler KL, Dominguez SR.

Neurology. 2019 Apr 30;92(18):e2118-e2126. doi: 10.1212/WNL.0000000000006670. Epub 2018 Nov 9.

PMID:
30413631
10.

Pediatric Bickerstaff brainstem encephalitis: a systematic review of literature and case series.

Santoro JD, Lazzareschi DV, Campen CJ, Van Haren KP.

J Neurol. 2018 Jan;265(1):141-150. doi: 10.1007/s00415-017-8684-8. Epub 2017 Nov 24. Review.

PMID:
29177548
11.

Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.

Adang LA, Sherbini O, Ball L, Bloom M, Darbari A, Amartino H, DiVito D, Eichler F, Escolar M, Evans SH, Fatemi A, Fraser J, Hollowell L, Jaffe N, Joseph C, Karpinski M, Keller S, Maddock R, Mancilla E, McClary B, Mertz J, Morgart K, Langan T, Leventer R, Parikh S, Pizzino A, Prange E, Renaud DL, Rizzo W, Shapiro J, Suhr D, Suhr T, Tonduti D, Waggoner J, Waldman A, Wolf NI, Zerem A, Bonkowsky JL, Bernard G, van Haren K, Vanderver A; Global Leukodystrophy Initiative (GLIA) Consortium.

Mol Genet Metab. 2017 Sep;122(1-2):18-32. doi: 10.1016/j.ymgme.2017.08.006. Epub 2017 Aug 20.

PMID:
28863857
12.

Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.

Armangue T, Orsini JJ, Takanohashi A, Gavazzi F, Conant A, Ulrick N, Morrissey MA, Nahhas N, Helman G, Gordish-Dressman H, Orcesi S, Tonduti D, Stutterd C, van Haren K, Toro C, Iglesias AD, van der Knaap MS, Goldbach Mansky R, Moser AB, Jones RO, Vanderver A.

Mol Genet Metab. 2017 Nov;122(3):134-139. doi: 10.1016/j.ymgme.2017.07.006. Epub 2017 Jul 20.

13.

Postmortem Whole Exome Sequencing Identifies Novel EIF2B3 Mutation With Prenatal Phenotype in 2 Siblings.

Song H, Haeri S, Vogel H, van der Knaap M, Van Haren K.

J Child Neurol. 2017 Sep;32(10):867-870. doi: 10.1177/0883073817712588. Epub 2017 Jun 9.

PMID:
28597716
14.

Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?

Van Haren K, Engelen M.

JAMA Neurol. 2017 Jun 1;74(6):641-642. doi: 10.1001/jamaneurol.2017.0095. No abstract available.

PMID:
28418445
15.

Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.

Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL.

Neurology. 2016 Aug 30;87(9 Suppl 2):S38-45. doi: 10.1212/WNL.0000000000002825. Review.

PMID:
27572859
16.

Acute flaccid myelitis: A clinical review of US cases 2012-2015.

Messacar K, Schreiner TL, Van Haren K, Yang M, Glaser CA, Tyler KL, Dominguez SR.

Ann Neurol. 2016 Sep;80(3):326-38. doi: 10.1002/ana.24730. Epub 2016 Aug 4. Review.

17.

Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015.

Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, Glenn-Finer R, Padilla T, Strober JB, Aldrovandi G, Wadford DA, Chiu CY, Xia D, Harriman K, Watt JP, Glaser CA.

JAMA. 2015 Dec 22-29;314(24):2663-71. doi: 10.1001/jama.2015.17275.

PMID:
26720027
18.

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.

Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, Gocke A, Steinman L, Mowry EM, Calabresi PA.

Neurology. 2016 Jan 26;86(4):382-90. doi: 10.1212/WNL.0000000000002316. Epub 2015 Dec 30.

19.

Magnetic resonance imaging spectrum of succinate dehydrogenase-related infantile leukoencephalopathy.

Helman G, Caldovic L, Whitehead MT, Simons C, Brockmann K, Edvardson S, Bai R, Moroni I, Taylor JM, Van Haren K; SDH Study Group, Taft RJ, Vanderver A, van der Knaap MS.

Ann Neurol. 2016 Mar;79(3):379-86. doi: 10.1002/ana.24572. Epub 2016 Feb 12. Erratum in: Ann Neurol. 2018 Sep;84(3):481.

20.

Emerging treatments for pediatric leukodystrophies.

Helman G, Van Haren K, Escolar ML, Vanderver A.

Pediatr Clin North Am. 2015 Jun;62(3):649-66. doi: 10.1016/j.pcl.2015.03.006. Epub 2015 Apr 8. Review.

21.

A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study.

Greninger AL, Naccache SN, Messacar K, Clayton A, Yu G, Somasekar S, Federman S, Stryke D, Anderson C, Yagi S, Messenger S, Wadford D, Xia D, Watt JP, Van Haren K, Dominguez SR, Glaser C, Aldrovandi G, Chiu CY.

Lancet Infect Dis. 2015 Jun;15(6):671-82. doi: 10.1016/S1473-3099(15)70093-9. Epub 2015 Mar 31.

22.

Disease specific therapies in leukodystrophies and leukoencephalopathies.

Helman G, Van Haren K, Bonkowsky JL, Bernard G, Pizzino A, Braverman N, Suhr D, Patterson MC, Ali Fatemi S, Leonard J, van der Knaap MS, Back SA, Damiani S, Goldman SA, Takanohashi A, Petryniak M, Rowitch D, Messing A, Wrabetz L, Schiffmann R, Eichler F, Escolar ML, Vanderver A; GLIA Consortium.

Mol Genet Metab. 2015 Apr;114(4):527-36. doi: 10.1016/j.ymgme.2015.01.014. Epub 2015 Feb 7.

23.

Consensus statement on preventive and symptomatic care of leukodystrophy patients.

Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC; GLIA Consortium.

Mol Genet Metab. 2015 Apr;114(4):516-26. doi: 10.1016/j.ymgme.2014.12.433. Epub 2014 Dec 27.

PMID:
25577286
24.

Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014.

Ayscue P, Van Haren K, Sheriff H, Waubant E, Waldron P, Yagi S, Yen C, Clayton A, Padilla T, Pan C, Reichel J, Harriman K, Watt J, Sejvar J, Nix WA, Feikin D, Glaser C; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Oct 10;63(40):903-6.

25.

De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy.

Lee JR, Srour M, Kim D, Hamdan FF, Lim SH, Brunel-Guitton C, Décarie JC, Rossignol E, Mitchell GA, Schreiber A, Moran R, Van Haren K, Richardson R, Nicolai J, Oberndorff KM, Wagner JD, Boycott KM, Rahikkala E, Junna N, Tyynismaa H, Cuppen I, Verbeek NE, Stumpel CT, Willemsen MA, de Munnik SA, Rouleau GA, Kim E, Kamsteeg EJ, Kleefstra T, Michaud JL.

Hum Mutat. 2015 Jan;36(1):69-78. doi: 10.1002/humu.22709. Epub 2014 Nov 27.

PMID:
25265257
26.

National variation in costs and mortality for leukodystrophy patients in US children's hospitals.

Brimley CJ, Lopez J, van Haren K, Wilkes J, Sheng X, Nelson C, Korgenski EK, Srivastava R, Bonkowsky JL.

Pediatr Neurol. 2013 Sep;49(3):156-162.e1. doi: 10.1016/j.pediatrneurol.2013.06.006.

27.

Therapeutic advances in pediatric multiple sclerosis.

Van Haren K, Waubant E.

J Pediatr. 2013 Sep;163(3):631-7. doi: 10.1016/j.jpeds.2013.04.028. Epub 2013 May 30. Review. No abstract available.

PMID:
23726542
28.

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.

Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T, Tenembaum SN, Pohl D, Rostasy K, Dale RC, O'Connor KC, Hafler DA, Steinman L, Robinson WH.

Mult Scler. 2013 Nov;19(13):1726-33. doi: 10.1177/1352458513485653. Epub 2013 Apr 23.

29.

Case report of subdural hematoma in a patient with Sturge-Weber syndrome and literature review: questions and implications for therapy.

Lopez J, Yeom KW, Comi A, Van Haren K.

J Child Neurol. 2013 May;28(5):672-5. doi: 10.1177/0883073812449514. Epub 2012 Jul 17. Review.

PMID:
22805242
30.

Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation.

Ho PP, Kanter JL, Johnson AM, Srinagesh HK, Chang EJ, Purdy TM, van Haren K, Wikoff WR, Kind T, Khademi M, Matloff LY, Narayana S, Hur EM, Lindstrom TM, He Z, Fiehn O, Olsson T, Han X, Han MH, Steinman L, Robinson WH.

Sci Transl Med. 2012 Jun 6;4(137):137ra73. doi: 10.1126/scitranslmed.3003831.

31.

Immune response in leukodystrophies.

Eichler F, Van Haren K.

Pediatr Neurol. 2007 Oct;37(4):235-44. Review.

PMID:
17903666
32.

The unfolded protein response in vanishing white matter disease.

van der Voorn JP, van Kollenburg B, Bertrand G, Van Haren K, Scheper GC, Powers JM, van der Knaap MS.

J Neuropathol Exp Neurol. 2005 Sep;64(9):770-5.

PMID:
16141786
33.

The life and death of oligodendrocytes in vanishing white matter disease.

Van Haren K, van der Voorn JP, Peterson DR, van der Knaap MS, Powers JM.

J Neuropathol Exp Neurol. 2004 Jun;63(6):618-30.

PMID:
15217090

Supplemental Content

Loading ...
Support Center